Metalloproteinase regulation improves in vitro generation of efficacious platelets from mouse embryonic stem cells

Journal of Experimental Medicine

Volumn 205, Issue 8, 2008, Pages 1917-1927

  Nishikii, Hidekazu ^a   Eto, Koji ^a   Tamura, Noriko ^b   Hattori, Koichi ^a   Heissig, Beate ^a   Kanaji, Taisuke ^c   Sawaguchi, Akira ^d   Goto, Shinya ^b   Ware, Jerry ^e   Nakauchi, Hiromitsu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF MIYAZAKI   (Japan)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALPHA2 INTEGRIN; GLYCOPROTEIN; GLYCOPROTEIN IB ALPHA; GLYCOPROTEIN V; GLYCOPROTEIN VI; ILOMASTAT; INTEGRIN ALPHA 2B; METALLOPROTEINASE; STEM CELL FACTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL SELECTION; CONTROLLED STUDY; CONVALESCENCE; EMBRYO; EMBRYONIC STEM CELL; ENZYME REGULATION; FLOW CYTOMETRY; HEMOSTASIS; IN VITRO STUDY; IN VIVO STUDY; MEGAKARYOPOIESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOCYTE FUNCTION; THROMBOGENESIS; TRANSFUSION;

ANIMALS; BLOOD PLATELETS; CELLS, CULTURED; DIPEPTIDES; EMBRYONIC STEM CELLS; INTEGRIN BETA3; MEGAKARYOCYTES; METALLOPROTEASES; MICE; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET MEMBRANE GLYCOPROTEIN IIB; PROTEASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-KIT; THROMBOPOIESIS; THROMBOSIS;

EID: 49249092802     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20071482     Document Type: Article

References (59)

1. Webb, I.J., and K.C. Anderson. 1999. Risks, costs, and alternatives to platelet transfusions. Leuk. Lymphoma. 34:71-84.
2. McCullough, J. 2000. Current issues with platelet transfusion in patients with cancer. Semin. Hematol. 37:3-10.
3. Berger, G., D.W. Hartwell, and D.D. Wagner. 1998. P-Selectin and platelet clearance. Blood. 92:4446-4452.
4. Matsunaga, T., I. Tanaka, M. Kobune, Y. Kawano, M. Tanaka, K. Kuribayashi, S. Iyama, T. Sato, Y. Sato, R. Takimoto, et al. 2006. Ex vivo large-scale generation of human platelets from cord blood CD34+ cells. Stem Cells. 24:2877-2887.
5. Keller, G. 2005. Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev. 19:1129-1155.
6. Asano, T., K. Sasaki, Y. Kitano, K. Terao, and Y. Hanazono. 2006. In vivo tumor formation from primate embryonic stem cells. Methods Mol. Biol. 329:459-467.
7. van der Meer, P.F., and R.N. Pietersz. 2005. Gamma irradiation does not affect 7-day storage of platelet concentrates. Vox Sang. 89:97-99.
8. Fujimoto, T.T., S. Kohata, H. Suzuki, H. Miyazaki, and K. Fujimura. 2003. Production of functional platelets by differentiated embryonic stem (ES) cells in vitro. Blood. 102:4044-4051.
9. Eto, K., R. Murphy, S.W. Kerrigan, A. Bertoni, H. Stuhlmann, T. Nakano, A.D. Leavitt, and S.J. Shattil. 2002. Megakaryocytes derived from embryonic stem cells implicate CalDAG-GEFI in integrin signaling. Proc. Natl. Acad. Sci. USA. 99:12819-12824.
10. Ruggeri, Z.M. 2002. Platelets in atherothrombosis. Nat. Med. 8:1227-1234.
11. Nieswandt, B., and S.P. Watson. 2003. Platelet-collagen interaction: is GPVI the central receptor? Blood. 102:449-461.
12. Bergmeier, W., C.L. Piffath, T. Goerge, S.M. Cifuni, Z.M. Ruggeri, J. Ware, and D.D. Wagner. 2006. The role of platelet adhesion receptor GPIbalpha far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis. Proc. Natl. Acad. Sci. USA. 103:16900-16905.
13. Canobbio, I., C. Balduini, and M. Torti. 2004. Signalling through the platelet glycoprotein Ib-V-IX complex. Cell. Signal. 16:1329-1344.
14. Berndt, M.C., Y. Shen, S.M. Dopheide, E.E. Gardiner, and R.K. Andrews. 2001. The vascular biology of the glycoprotein Ib-IX-V complex. Thromb. Haemost. 86:178-188.
15. Rabie, T., A. Strehl, A. Ludwig, and B. Nieswandt. 2005. Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V. J. Biol. Chem. 280:14462-14468.
16. Bergmeier, W., C.L. Piffath, G. Cheng, V.S. Dole, Y. Zhang, U.H. von Andrian, and D.D. Wagner. 2004. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates GPIbalpha shedding from platelets in vitro and in vivo. Circ. Res. 95:677-683.
17. Bergmeier, W., P.C. Burger, C.L. Piffath, K.M. Hoffmeister, J.H. Hartwig, B. Nieswandt, and D.D. Wagner. 2003. Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro-aged or -injured mouse platelets. Blood. 102:4229-4235.
18. Goto, S., N. Tamura, H. Ishida, and Z.M. Ruggeri. 2006. Dependence of platelet thrombus stability on sustained glycoprotein IIb/IIIa activation through adenosine 5′-diphosphate receptor stimulation and cyclic calcium signaling. J. Am. Coll. Cardiol. 47:155-162.
19. Shattil, S.J., and P.J. Newman. 2004. Integrins: dynamic scaffolds for adhesion and signaling in platelets. Blood. 104:1606-1615.
20. Takahashi, K., and S. Yamanaka. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 126:663-676.
21. Hanna, J., M. Wernig, S. Markoulaki, C.W. Sun, A. Meissner, J.P. Cassady, C. Beard, T. Brambrink, L.C. Wu, T.M. Townes, and R. Jaenisch. 2007. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science. 318:1920-1923.
22. Nakorn, T.N., T. Miyamoto, and I.L. Weissman. 2003. Characterization of mouse clonogenic megakaryocyte progenitors. Proc. Natl. Acad. Sci. USA. 100:205-210.
23. Zhang, J., F. Varas, M. Stadtfeld, S. Heck, N. Faust, and T. Graf. 2007. CD41-YFP mice allow in vivo labeling of megakaryocytic cells and reveal a subset of platelets hyperreactive to thrombin stimulation. Exp. Hematol. 35:490-499.
24. Kyba, M., R.C. Perlingeiro, and G.Q. Daley. 2002. HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell. 109:29-37.
25. Zhang, W.J., C. Park, E. Arentson, and K. Choi. 2005. Modulation of hematopoietic and endothelial cell differentiation from mouse embryonic stem cells by different culture conditions. Blood. 105:111-114.
26. Nakano, T., H. Kodama, and T. Honjo. 1994. Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science. 265:1098-1101.
27. Nishikawa, S.I., S. Nishikawa, M. Hirashima, N. Matsuyoshi, and H. Kodama. 1998. Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages. Development. 125:1747-1757.
28. Hashimoto, Y., and J. Ware. 1995. Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene. J. Biol. Chem. 270:24532-24539.
29. Ohmori, T., J. Mimuro, K. Takano, S. Madoiwa, Y. Kashiwakura, A. Ishiwata, M. Niimura, K. Mitomo, T. Tabata, M. Hasegawa, et al. 2006. Efficient expression of a transgene in platelets using simian immunodeficiency virus-based vector harboring glycoprotein Ibalpha promoter: in vivo model for platelet-targeting gene therapy. FASEB J. 20:1522-1524.
30. Lavenu-Bombled, C., B. Izac, F. Legrand, M. Cambot, A. Vigier, J.M. Masse, and A. Dubart-Kupperschmitt. 2007. Glycoprotein Ibalpha promoter drives megakaryocytic lineage-restricted expression after hematopoietic stem cell transduction using a SIN lentiviral vector. Stem Cells. 25:1571-1577.
31. Fujita, H., Y. Hashimoto, S. Russell, B. Zieger, and J. Ware. 1998. In vivo expression of murine platelet glycoprotein Ibalpha. Blood. 92:488-495.
32. Fraser, S.T., M. Ogawa, R.T. Yu, S. Nishikawa, M.C. Yoder, and S. Nishikawa. 2002. Definitive hematopoietic commitment within the embryonic vascular endothelial-cadherin(+) population. Exp. Hematol. 30:1070-1078.
33. Lepage, A., M. Leboeuf, J.P. Cazenave, C. de la Salle, F. Lanza, and G. Uzan. 2000. The alpha(IIb)beta(3) integrin and GPIb-V-IX complex identify distinct stages in the maturation of CD34(+) cord blood cells to megakaryocytes. Blood. 96:4169-4177.
34. Shivdasani, R.A. 2001. Molecular and transcriptional regulation of megakaryocyte differentiation. Stem Cells. 19:397-407.
35. Schulze, H., and R.A. Shivdasani. 2005. Mechanisms of thrombopoiesis. J. Thromb. Haemost. 3:1717-1724.
36. Tober, J., A. Koniski, K.E. McGrath, R. Vemishetti, R. Emerson, K.K. de Mesy-Bentley, R. Waugh, and J. Palis. 2007. The megakaryocyte lineage originates from hemangioblast precursors and is an integral component both of primitive and of definitive hematopoiesis. Blood. 109:1433-1441.
37. Lane, W.J., S. Dias, K. Hattori, B. Heissig, M. Choy, S.Y. Rabbany, J. Wood, M.A. Moore, and S. Rafii. 2000. Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases. Blood. 96:4152-4159.
38. Stephens, G., Y. Yan, M. Jandrot-Perrus, J.L. Villeval, K.J. Clemetson, and D.R. Phillips. 2005. Platelet activation induces metalloproteinase-dependent GP VI cleavage to down-regulate platelet reactivity to collagen. Blood. 105:186-191.
39. Clarke, M.C., J. Savill, D.B. Jones, B.S. Noble, and S.B. Brown. 2003. Compartmentalized megakaryocyte death generates functional platelets committed to caspase-independent death. J. Cell Biol. 160:577-587.
40. Nieswandt, B., M. Moser, I. Pleines, D. Varga-Szabo, S. Monkley, D. Critchley, and R. Fassler. 2007. Loss of talin1 in platelets abrogates integrin activation, platelet aggregation, and thrombus formation in vitro and in vivo. J. Exp. Med. 204:3113-3118.
41. Yap, C.L., K.E. Anderson, S.C. Hughan, S.M. Dopheide, H.H. Salem, and S.P. Jackson. 2002. Essential role for phosphoinositide 3-kinase in shear-dependent signaling between platelet glycoprotein Ib/V/IX and integrin alpha(IIb)beta(3). Blood. 99:151-158.
42. Falati, S., P. Gross, G. Merrill-Skoloff, B.C. Furie, and B. Furie. 2002. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat. Med. 8:1175-1181.
43. Hoffmeister, K.M., T.W. Felbinger, H. Falet, C.V. Denis, W. Bergmeier, T.N. Mayadas, U.H. von Andrian, D.D. Wagner, T.P. Stossel, and J.H. Hartwig. 2003. The clearance mechanism of chilled blood platelets. Cell. 112:87-97.
44. Junt, T., H. Schulze, Z. Chen, S. Massberg, T. Goerge, A. Krueger, D.D. Wagner, T. Graf, J.E. Italiano Jr., R.A. Shivdasani, and U.H. von Andrian. 2007. Dynamic visualization of thrombopoiesis within bone marrow. Science. 317:1767-1770.
45. Kasirer-Friede, A., M.R. Cozzi, M. Mazzucato, L. De Marco, Z.M. Ruggeri, and S.J. Shattil. 2004. Signaling through GP Ib-IX-V activates alpha IIb beta 3 independently of other receptors. Blood. 103:3403-3411.
46. Santos-Martinez, M.J., C. Medina, P. Jurasz, and M.W. Radomski. 2007. Role of metalloproteinases in platelet function. Thromb. Res. 121:535-542.
47. Amour, A., P.M. Slocombe, A. Webster, M. Butler, C.G. Knight, B.J. Smith, P.E. Stephens, C. Shelley, M. Hutton, V. Knauper, et al. 1998. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett. 435:39-44.
48. Radomski, A., P. Jurasz, E.J. Sanders, C.M. Overall, H.F. Bigg, D.R. Edwards, and M.W. Radomski. 2002. Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets. Br. J. Pharmacol. 137:1330-1338.
49. Zimmerman, G.A., and A.S. Weyrich. 2008. Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function. Arterioscler. Thromb. Vasc. Biol. 28:s17-s24.
50. Heissig, B., K. Hattori, S. Dias, M. Friedrich, B. Ferris, N.R. Hackett, R.G. Crystal, P. Besmer, D. Lyden, M.A. Moore, et al. 2002. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 109:625-637.
51. Falcinelli, E., G. Guglielmini, M. Torti, and P. Gresele. 2005. Intraplatelet signaling mechanisms of the priming effect of matrix metalloproteinase-2 on platelet aggregation. J. Thromb. Haemost. 3:2526-2535.
52. Fernandez-Patron, C., M.A. Martinez-Cuesta, E. Salas, G. Sawicki, M. Wozniak, M.W. Radomski, and S.T. Davidge. 1999. Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2. Thromb. Haemost. 82:1730-1735.
53. Sheu, J.R., T.H. Fong, C.M. Liu, M.Y. Shen, T.L. Chen, Y. Chang, M.S. Lu, and G. Hsiao. 2004. Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies. Br. J. Pharmacol. 143:193-201.
54. Houwerzijl, E.J., N.R. Blom, J.J. van der Want, M.T. Esselink, J.J. Koornstra, J.W. Smit, H. Louwes, E. Vellenga, and J.T. de Wolf. 2004. Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura. Blood. 103:500-506.
55. Gardiner, E.E., D. Karunakaran, Y. Shen, J.F. Arthur, R.K. Andrews, and M.C. Berndt. 2007. Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. J. Thromb. Haemost. 5:1530-1537.
56. Josefsson, E., V. Rumjantseva, C. Dahlgren, W. Bergmeier, D. Wagner, J. Hartwig, and K. Hoffmeister. 2007. Metalloproteinase Inhibitors Increase the Survival of Long-Term Refrigerated Platelets in Mice. Blood. (ASH Annual Meeting Abstracts) 110:419.
57. Mohler, K.M., P.R. Sleath, J.N. Fitzner, D.P. Cerretti, M. Alderson, S.S. Kerwar, D.S. Torrance, C. Otten-Evans, T. Greenstreet, K. Weerawarna, et al. 1994. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature. 370:218-220.
58. Doetschman, T., R.G. Gregg, N. Maeda, M.L. Hooper, D.W. Melton, S. Thompson, and O. Smithies. 1987. Targetted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature. 330:576-578.
59. Goto, S., N. Tamura, S. Handa, M. Arai, K. Kodama, and H. Takayama. 2002. Involvement of glycoprotein VI in platelet thrombus formation on both collagen and von Willebrand factor surfaces under flow conditions. Circulation. 106:266-272.